Current Status And Typical Case Reports Of Malignant Pericardial Effusion In Traditional Chinese And Western Medicine

Cancerous hydropericardia is one of the most commom complications of advanced cancers. Most scholars believe that malignant pericardial effusion will not affect the survival of patients. While one-third of patients with malignant pericardial effusion will eventually die of cardiac tamponade, and the rest die of heart failure and systemic failure. However, the treatment of malignant pericardial effusion in a certain extent, also result in death, this at about 41% to 45%.There are many treatments of malignant pericardial effusion at present in the clinical, many of which have certain curative effect in the short term. However the malignant pericardial effusion is easy to repeated attacks, and the recurrence after treatment more difficult. Modern medical treatment of malignant pericardial effusion including local surgery, pericardial cavity infusion therapy, physical therapy and other methods in the current clinical, each has its advantages and disadvantages.The traditional Chinese Medicine had no direct description of " malignant pericardial effusion ", in addition to descriptions of edema, ballooning, palpitation, suspended drink, and a drink et. There is not much difference about the understanding of malignant pericardial effusion between the traditional TCM and the today’s, both of them treat malignant pericardial effusion based on syndrome differentiation from the suspended drink, drink, swelling, edema and heart palpitations et. The TCM treats malignant pericardial effusion according to the specific situation and combining with local and systemic dialectical dialectical.Method:By searching synthesizing and summarizing a large number of documents, this summarizes the progress about the treatment of malignant pericardial effusion in the TCM and the modern medicine. And it provides ideas and methods for the treatment of malignant pericardial effusion. This paper statistics treatments for the lung cancer patients suffering malignant pericardial effusion in the hospital of DongFang Hospital from October 2009 to October 2014. And it reports a typical case about using HuaChanSu injection to treat a patient who simultaneously suffering advanced lung cancer and malignant pericardial effusion.Objective:To provide a new method and direction for clinical treatment of malignant pericardial effusion.The framework of this paper includes literature review, case statistics, report of a typical case, summary and discussion.There are two subjects in this paper. The subject 1 introduces the cognition and treatment progress of malignant pericardial effusion in modern medicine. The treatment consists of local surgical procedures, intracavitaryinfusion, and physical therapy et. Local surgery concludes pericardial drainage, pericardial fenestration, partial excision of pericardial effusion, etc. Intravesical therapy drugs include hardening agents, biological agents, cytotoxicdrugs, other drugs, and drugs combined. Physical therapy includes hyperthermia. This subject also points out the main side effects of all these treatments,and the limitation in the climical.The subject 2 introduces the dialectical logic and the treatment of malignant pericardial effusion in TCM.The treatments of malignant pericardial effusion include TCM herb-decoction, intravenous drip of Chinese patent medicine, intravenous infusion of Chinese patent medicine, administration,TCM perfusion, criticize the secondary andexternal application of Chinese herbs in the cavity of auxiliary, acupuncture and moxibustion and external application of Chinese herbs in TCM at present. The TCM is accepted by the majority of patients because of its milder side reactions, better relieving patients’ pain compared with the modern medcine.While the TCM has its limitations with acute pericardial tamponade and too mucn pericardial effusion volume. Modern medical surgical treatment such as pericardio-centesis should be used.Part of the body is about the treatment to all the patients simultaneously suffering advanced lung cancer and malignant pericardial effusion, during their hospitalization in DongFang Hosptial form October 2009 to October 2014.The rest part is about a typical case of using HuaChanSu injection to treat a patient who simultaneously suffering advanced lung cancer and malignant pericardial effusion. And this provides a new method and direction for clinical treatment of malignant pericardial effusion.